ABBOTT LABORATORIES — Director's Dealing 2011

Nov 3, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2011-09-08

Reporting Person: Michael Edward L (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-09-08	Common shares without par value	G	5000	$.00	Disposed	214865	Direct
2011-11-01	Common shares without par value	M	42561	$41.0317	Acquired	257426	Direct
2011-11-01	Common shares without par value	M	10640	$40.9941	Acquired	268066	Direct
2011-11-01	Common shares without par value	F	45530	$53.87	Disposed	222536	Direct
2011-11-01	Common shares without par value	S	4800	$53.242	Disposed	217736	Direct
2011-11-01	Common shares without par value	S	2286	$53.241	Disposed	215450	Direct
2011-11-01	Common shares without par value	S	8000	$53.10	Disposed	207450	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-11-01	Option (right to buy)	$41.0317	M	42561	Disposed	2014-02-19	Common shares (42561)	Direct
2011-11-01	Option (right to buy)	$40.9941	M	10640	Disposed	2013-07-14	Common shares (10640)	Direct
2011-11-01	Option (right to buy)	$53.87	A	36379	Acquired	2014-02-19	Common shares (36379)	Direct
2011-11-01	Option (right to buy)	$53.87	A	9151	Acquired	2013-07-14	Common shares (9151)	Direct

Footnotes

F1: Transaction made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.